HOME › DRUGS › RESPIRATORY SYNCYTIAL VIRUS VACCINE (BIVALENT, RECOMBINANT)
ACTIVE SUBSTANCE / INN

RESPIRATORY SYNCYTIAL VIRUS VACCINE (BIVALENT, RECOMBINANT)

Brand name(s): Abrysvo
EMA LISTED
AUTHORISED
Respiratory Syncytial Virus Infections
ACTIVE SUBSTANCE
Respiratory Syncytial Virus Vaccine (Bivalent, Recombinant)
REGULATORS
EMA
SPONSORS / MAH
Pfizer Europe MA EEIG
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
AbrysvoPfizer Europe MA EEIGAuthorised23/08/2023Respiratory Syncytial Virus Infections

FULL INTELLIGENCE ON RESPIRATORY SYNCYTIAL VIRUS VACCINE (BIVALENT, RECOMBINANT)

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →